PMD Heatlhcare Supports Pulmonary Fibrosis Month
Share: Share on Facebook Share on Twitter Share on LinkedIn
ALLENTOWN, Pa., Sept. 11, 2017 /PRNewswire/ — As a company with a strong heritage in helping patients with lung disease PMD Healthcare is proud to recognize and support Pulmonary Fibrosis month this September. PMD encourages everyone to become engaged, and educated about Pulmonary Fibrosis (PF).
Pulmonary Fibrosis (PF) is a term used to describe a family of diseases that affect the lungs. Pulmonary meaning “lung” and fibrosis meaning “scar tissue,” thus (PF) means scarring in the lungs. Over time scar tissue builds up in the lungs making it hard for oxygen to get into the blood. This results in a shortness of breath when walking or exercising. Often times it can be difficult for physicians to identify the cause of (PF), in such instances this is referred to as Idiopathic (no known cause) Pulmonary Fibrosis (IPF).
Since diagnosing PF can be difficult the Pulmonary Fibrosis Foundation strongly recommends that everyone with a suspected or established diagnosis of PF be seen at a center that specializes in the care of people with PF. This is very important because determining which type of Pulmonary Fibrosis you have can help predict how quickly your disease will progress, and what the best treatments are. You can find a list of PF centers on the Pulmonary Fibrosis Foundations website www.pulomanryfibrosis.org.
To assist in determining the correct diagnosis physicians will complete numerous tasks and test inclusive of your medical history, a physical exam, X-Ray’s, blood tests, pulmonary function test and other tests as needed.
Given the variability in progression of pulmonary fibrosis these is no standard treatment course. Since some patients remain stable for extended periods of time and other experience rapid onset of symptoms, treatment plans are highly customized to each individual patient.
About PMD Healthcare
Founded in 2010, PMD Healthcare is a Medical Device, Digital Health, and Chronic Care Management Service Company with a mission dedicated to creating innovative solutions that empower people to improve their healthcare and quality of life. With that intent focus, PMD developed the first ever personal spirometer, Spiro PD, which was approved by the FDA in 2011. PMD is now launching several new remote monitoring products including its second-generation spirometer, Spiro PD 2.0, and its HIPPA compliant Wellness Management System (WMS). To learn more about PMD Healthcare, please visit www.MyPMD.com.
About the Pulmonary Fibrosis Foundation
The Pulmonary Fibrosis Foundation mobilizes people and resources to provide access to high quality care and leads research for a cure so people with pulmonary fibrosis will live longer, healthier lives. The PFF collaborates with physicians, organizations, patients, and caregivers worldwide. The Pulmonary Fibrosis Foundation has a four-star rating from Charity Navigator and is a Better Business Bureau accredited charity.